AGO2 and non-small cell lung carcinoma: We found that the loading of highly abundant oncogenic miRNAs into AGO2 to form miRISC was increased in NSCLC, suggesting that intervening or reducing these oncogenic miRISC formation could be a promising antitumor therapeutic strategy.